BioSpace News Archive

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.61 billion for the second quarter ended April 30, 2022, an increase of 5% compared to the second quarter of 2021 and up 7% on a core(1) basis.

Increasing demand for gluconic acid in various end-use industries including food & beverage, personal care, and agriculture industries is expected to drive market growth

Castle Biosciences, Inc. (Nasdaq: CSTL), today announced new study data demonstrating the ability of its TissueCypher® Barrett’s Esophagus test to independently predict malignant progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in patients with non-dysplastic (ND), indefinite or low-grade dysplasia (LGD) Barrett’s esophagus (BE).

Continuous advances in medical technology and growing need for advanced physiological models are among the major factors boosting the global Organs-on-Chips (OOCs) market revenue growth.

Increasing prevalence of atrial fibrillation, advancements in AFib prediction and management, and improved precision in diagnosis of this condition are some key factors expected to drive market growth

Increasing elderly population globally, rising incidence of oral diseases among adults and children, and increasing focus on developing affordable dental implants are key factors fueling global market growth

Increasing prevalence of chronic diseases and digestive enzyme disorders, rapid technological advancements, and rising demand for effective therapeutics are some factors expected to drive global Specialty Enzymes market growth.

Increasing prevalence of chronic diseases across the globe, growing awareness about wearable injectors, and rising focus on developing advanced products are expected to drive global market growth

Rising prevalence of chronic disorders, increasing application of robotics in surgical procedures, and growing demand for minimally invasive surgeries are some key factors expected to drive global Robotics Surgical Simulation Systems market growth.

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2022 to all shareholders of record as of June 15, 2022.